Do you really think this company can pull this off, page-14

If they convert their pre-clinical results for 1801 into ph2 clinical success this will moon even in a poor market, in the current market, well who knows how far the nutters will run it. Can they convert is the question? Too much risk for me to hold into results now with no backup as it's pretty much game over if this trial fails but I'll certainly be watching for an entry after the results are out if they're good

I do think they also have the right people to get it commercialised but again, they need clinical trial success first.